Acadian Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,451
Closed -$243K – 2238
2026
Q1
$243K Sell
2,451
-6,667
-73% -$870K ﹤0.01% 1534
2025
Q4
$1.11M Buy
9,118
+8,647
+1,836% +$1.09M ﹤0.01% 1096
2025
Q3
$52K Buy
+471
New +$55.1K ﹤0.01% 1637
2024
Q4
– Sell
-2,248
Closed -$352K – 2159
2024
Q3
$352K Buy
+2,248
New +$346K ﹤0.01% 1175
2023
Q3
– Sell
-7,871
Closed -$661K – 1843
2023
Q2
$661K Buy
7,871
+3,994
+103% +$306K ﹤0.01% 983
2023
Q1
$293K Buy
+3,877
New +$268K ﹤0.01% 1179

Other funds holding TMDX

Acadian Asset Management's TMDX Position: Q2 2026 in Review

Acadian Asset Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,451 shares — an estimated $243K sold.

Acadian Asset Management first reported a position in TMDX in Q1 2023 and held it in 6 quarters. The position peaked at $1.11M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Acadian Asset Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 2,451 Transmedics shares in Q2 2026, an estimated $243K.
  • Acadian Asset Management first reported a position in Transmedics in Q1 2023 and held it in 6 quarters.
  • Acadian Asset Management's Transmedics position peaked at $1.11M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.